Filter
6173
Filtered Results: 6173
Text search:
medication
Featured
Recommendations
616
New Publications
1351
Language
Document type
No document type
3103
Studies & Reports
1083
Guidelines
889
Manuals
421
Strategic & Response Plan
202
Fact sheets
167
Training Material
150
Situation Updates
45
Brochures
43
Infographics
37
Resource Platforms
20
Online Courses
6
Videos
6
App
1
Countries / Regions
Global
310
India
256
South Africa
161
Kenya
155
Ethiopia
116
Western and Central Europe
112
Africa
108
Nigeria
96
Uganda
96
Tanzania
91
Sierra Leone
90
Nepal
88
Ukraine
79
Liberia
79
Zambia
78
Malawi
74
Ghana
73
Latin America and the Carribbean
69
Rwanda
67
Bangladesh
61
Syria
59
Namibia
55
Germany
54
Myanmar / Burma
54
Philippines
49
Congo, Democratic Republic of
49
South–East Asia Region
41
Zimbabwe
38
Eastern Europe
36
Lesotho
34
Asia
32
West and Central Africa
31
Indonesia
31
East and Southern Africa
30
South Sudan
28
Mozambique
27
Cambodia
27
Middle East and North Africa
27
Venezuela
26
Haiti
25
Russia
24
Burkina Faso
22
Guinea
22
Botswana
22
Cameroon
21
Eastern Europe and Central Asia
20
Senegal
19
Yemen
19
Brazil
17
Afghanistan
16
Jordan
16
Vietnam
16
Thailand
15
Benin
15
Colombia
14
Western Pacific Region
14
Lebanon
14
Pakistan
14
USA
13
Eswatini/ Swaziland
13
Tajikistan
12
Sudan
12
Central African Republic
12
China
11
Laos
11
Argentina
10
Sri Lanka
10
Albania
9
North America
9
Moldova
9
Mali
9
Somalia
9
Paraguay
8
Chile
7
Iran
7
Peru
7
Palestine
7
Georgia
7
Iraq
7
Madagascar
7
Côte d’Ivoire / Ivory Coast
6
Mexico
5
Serbia
5
Kyrgyzstan
5
United Kingdom
5
Papua New Guinea
5
Chad
5
Libya
5
Ecuador
5
North Macedonia
4
Timor Leste/ East Timor
4
Kazakhstan
4
Canada
4
Morocco
4
Jamaica
4
Spain
4
Southern Africa
4
Bolivia
4
Bhutan
4
Turkey
3
Estonia
3
Niger
3
Burundi
3
Malaysia
3
Guinea-Bissau
3
Saudi Arabia
3
Japan
3
Egypt
3
Romania
3
Angola
3
Guatemala
3
Switzerland
2
Gambia
2
Togo
2
Fiji
2
Mongolia
2
Bulgaria
2
Armenia
2
Hungary
2
Lithuania
2
Turkmenistan
2
Tunisia
2
Portugal
2
Azerbaijan
2
Belarus
2
Djibouti
2
Greece
2
Poland
2
North Korea
1
El Salvador
1
Australia
1
Singapore
1
Uzbekistan
1
Qatar
1
Croatia
1
Ireland
1
Gabon
1
Denmark
1
Mauritius
1
Norway
1
South Korea
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Guyana
1
Oman
1
Slovakia
1
Solomon Islands
1
Bahamas
1
Authors & Publishers
Publication Years
Category
Countries
2011
Clinical Guidelines
583
Public Health
419
Women & Child Health
335
Key Resources
273
Capacity Building
179
Pharmacy & Technologies
61
Annual Report MEDBOX
2
Toolboxes
Mental Health
737
HIV
489
COVID-19
440
TB
344
Caregiver
256
NCDs
254
Disability
204
AMR
200
NTDs
192
Refugee
186
Conflict
156
Planetary Health
145
Pharmacy
139
Ebola & Marburg
133
Malaria
91
Rapid Response
86
Global Health Education
79
2.0 Rapid Response
64
Natural Hazards
45
Health Financing Toolbox
42
Social Ethics
31
Zika
27
Specific Hazards
22
Cholera
22
Polio
22
South Sudan
1
Typhoon
1
Implementation reference guide. This Malaria Surveillance Assessment Toolkit implementation reference guide is a comprehensive reference document, as well as a step by-step guide. It aligns and adapts available tools into a single set of standardized tools, which can be used to conduct malaria surve...
Anopheles stephensi is an invasive mosquito species which has been found spreading across Africa. While this species presents a new challenge for malaria control on the continent, its surveillance and management have been ongoing in Asia for many years. This document aims to summarize key lessons fr...
2nd edition. The purpose of this document is to present updated standardized protocols that P. falciparum-endemic countries can use to determine the prevalence of parasites with pfhrp2/3 gene deletions causing negative HRP2 RDT results among symptomatic falciparum patients. The findings should be us...
Preferred product characteristics and clinical development considerations
The aim of this protocol is to support the conduct of entomological comparative efficacy assessments for vector control products and the associated non-inferiority analysis. This evidence is used to inform discussions within the guidelines development context as to whether a new vector control prod...
The purpose of the guideline is to provide information to stakeholders on the necessary requirements for a complete prequalification dossier for insecticide-treated nets (ITNs). Its aim is to establish the baseline for dossier requirements which are necessary to assess ITN products for the purposes ...
A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large-scale funding cuts from international donors are having on countries most affected by HIV. Yet it a...
A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large-scale funding cuts from international donors are having on countries most affected by HIV. Yet it a...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This global guidance was developed to support malaria-free countries and those that are close to malaria elimination to prevent re-establishment. The document outlines key concepts and principles for preventing re-establishment and provides guidance on strategies, interventions, planning and managem...
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers and partners to plan and implement readiness and response activities for Ebola disease outbreaks. The toolkit conta...
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers, and partners to plan and implement readiness and response activities for yellow fever outbreaks. The toolkit conta...
This guide provides strategic direction for host countries, event organizers, health authorities, and key stakeholders to effectively plan and conduct Simulation Exercises (SimEx) and After Action Reviews (AARs) for mass gathering events. Packed with practical tools, it empowers users to seamlessly ...
This publication provides guidance for planning country-specific programming to achieve the triple elimination of mother-to-child (or vertical) transmission of HIV, syphilis and hepatitis B virus. It is based on the WHO Triple Elimination Framework, which promotes an integrated, person-centred appro...
National tuberculosis (TB) prevalence surveys provide a nationally representative measurement of the burden of TB disease in the population, at a given point in time. Repeat surveys allow assessment of trends and tracking of progress towards national and global targets for reductions in TB disease b...
This operational guidance provides a structured approach to support countries in sustaining priority services for HIV, viral hepatitis and sexually transmitted infections in the context of reduced external funding. The guidance is intended for national governments, public health programmes, communit...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
Buruli ulcer (BU) is a skin-related neglected tropical disease (skin NTD) caused by infection with
Mycobacterium ulcerans. BU is the third most common mycobacterial disease after tuberculosis and leprosy
in people who are not immunocompromised. The infection manifests in non-ulcerative forms as no...
